Antineoplastic AgentsNeoplasmsCell Line, TumorDrug Screening Assays, AntitumorRadiation, IonizingRadiation DosageDrug Resistance, NeoplasmRadiation InjuriesApoptosisDoxorubicinAntineoplastic Agents, PhytogenicBreast NeoplasmsCell SurvivalRadiation ToleranceDose-Response Relationship, RadiationDrug Delivery SystemsMice, NudeCisplatinXenograft Model Antitumor AssaysAntibiotics, AntineoplasticTumor Cells, CulturedRadiationCell ProliferationDrug CarriersColonic NeoplasmsLung NeoplasmsRadiation ProtectionGene Expression Regulation, NeoplasticPaclitaxelRadiation MonitoringProstatic NeoplasmsDNA DamageCamptothecinDose-Response Relationship, DrugRadiotherapyInhibitory Concentration 50EllipticinesCombined Modality TherapyCell CycleDrug SynergismDrug Resistance, MultipleOvarian NeoplasmsEtoposideMolecular Targeted TherapyAntineoplastic Combined Chemotherapy ProtocolsDrug DesignP-GlycoproteinFluorouracilNeoplasm ProteinsEarly Detection of CancerNeoplasm TransplantationRadiation OncologyProdrugsMolecular StructureTumor Suppressor Protein p53Medical OncologyEnzyme InhibitorsRadiation-Sensitizing AgentsClinical Trials as TopicNational Cancer Institute (U.S.)NanomedicineNanoparticlesBlotting, WesternNeoplasm MetastasisPancreatic NeoplasmsSignal TransductionAntimetabolites, AntineoplasticPlant ExtractsRNA, Small InterferingCell DivisionNeoplasms, Radiation-InducedOrganoplatinum CompoundsTransplantation, HeterologousNeoplasms, ExperimentalDrug Evaluation, PreclinicalTumor BurdenTime FactorsStomach NeoplasmsHCT116 CellsGamma RaysMCF-7 CellsAdenocarcinomaModels, BiologicalNeoplasm InvasivenessDNA Topoisomerases, Type IICaspasesRNA, MessengerDrug DiscoveryHT29 CellsProto-Oncogene Proteins c-bcl-2Flow CytometryDNA RepairAnticarcinogenic AgentsTreatment OutcomeSurvivorsCarcinoma, Squamous CellTopoisomerase I InhibitorsNanocapsulesCaspase 3Down-Regulation